Drugs
LONDON, UNITED KINGDOM and SOUTH SAN FRANCISCO, CA: LONDON, UNITED KINGDOM and SOUTH SAN FRANCISCO, CA -- (Marketwired) -- 02/09/15 -- GlaxoSmithKline plc (LSE: GSK) (NYSE: GSK) and Theravance, Inc. (NASDAQ: THRX) today announced the start of a second ...
SOUTH SAN FRANCISCO, CA: SOUTH SAN FRANCISCO, CA -- (Marketwired) -- 02/06/15 -- Theravance, Inc. (NASDAQ: THRX) today announced that on March 19, 2015, the U.S. Food and Drug Administration's Pulmonary-Allergy Drugs Ad ...
SOUTH SAN FRANCISCO, CA: SOUTH SAN FRANCISCO, CA -- (Marketwired) -- 02/05/15 -- Global Blood Therapeutics (GBT), a clinical stage biopharmaceutical company developing novel small molecule therapeutics for the treatment of s ...
BUFFALO, NY: BUFFALO, NY -- (Marketwired) -- 02/05/15 -- (NASDAQ: CBLI) today announced that the Company is scheduled to present at the 2015 BIO CEO & Investor Conference, February 9-10, in New York, NY.Yako ...
CLARKSVILLE, MD: CLARKSVILLE, MD -- (Marketwired) -- 02/05/15 -- The US Patent Office issued an allowance to Neuronascent, Inc. expanding patent protection of their new therapeutic candidate, NNI-362, beyond composit ...
TORONTO, ONTARIO: TORONTO, ONTARIO -- (Marketwired) -- 02/04/15 -- Merus Labs International Inc. (TSX: MSL)(NASDAQ: MSLI) ("Merus" or "the Company") today announced the appointment of Geoff Morrow ...
DUBLIN, IRELAND: DUBLIN, IRELAND -- (Marketwired) -- 01/29/15 -- Horizon Pharma plc (NASDAQ: HZNP), a specialty biopharmaceutical company focused on improving patients' lives by identifying, developing, acquirin ...
BUFFALO, NY: BUFFALO, NY -- (Marketwired) -- 01/29/15 -- (NASDAQ: CBLI) today announced updates on oncology clinical development of entolimod (previously known as CBLB502).Entolimod is a toll-like receptor 5 (TLR ...
PARIS, FRANCE: PARIS, FRANCE -- (Marketwired) -- 01/29/15 --PARIS, FRANCE, January 29th2015: OSE Pharma, a biotechnology company developing T-cell specific immunotherapy, and Simbec-Orion, a leading global clinical ...
MELBOURNE, AUSTRALIA: MELBOURNE, AUSTRALIA -- (Marketwired) -- 01/29/15 -- Molecular diagnostics company Genetic Technologies Limited (ASX: GTG) (NASDAQ: GENE) ("Company") is pleased to report that up to 6 new b ...
FOSTER CITY, CA: FOSTER CITY, CA -- (Marketwired) -- 01/28/15 -- SciClone Pharmaceuticals, Inc. (NASDAQ: SCLN) today announced that Friedhelm Blobel, Ph.D., Chief Executive Officer, will present a corporate overview ...
BUFFALO, NY: BUFFALO, NY -- (Marketwired) -- 01/28/15 -- (NASDAQ: CBLI) today announced the appointment of Elena Kasimova of BioProcess Capital Partners to the Company's Board of Directors. Ms. Kasimova was ...
FOSTER CITY, CA: FOSTER CITY, CA -- (Marketwired) -- 01/28/15 -- SciClone Pharmaceuticals, Inc. (NASDAQ: SCLN) today announced that Friedhelm Blobel, Ph.D., Chief Executive Officer, will present a corporate overview ...
PHOENIX, AZ: PHOENIX, AZ -- (Marketwired) -- 01/26/15 -- Insys Therapeutics, Inc. (NASDAQ: INSY), a specialty pharmaceutical company that is developing and commercializing innovative drugs and novel drug delivery ...
MONTREAL, CANADA: MONTREAL, CANADA -- (Marketwired) -- 01/22/15 -- Knight Therapeutics Inc. (TSX: GUD), through one of its wholly owned subsidiaries ("Knight"), announced today that it has entered into a se ...
MONTREAL, CANADA: MONTREAL, CANADA -- (Marketwired) -- 01/21/15 -- Knight Therapeutics Inc. (TSX: GUD) ("Knight") announced today (i) the resignation of Hillel Rosen and (ii) the appointment Ed Schutter to ...
TORONTO, ONTARIO: TORONTO, ONTARIO -- (Marketwired) -- 01/15/15 -- A correction from source is being issued for the Canadian Cannabis Corp. release that was disseminated on January 13, 2015 at 16:35 ET. In the first ...
LYON, FRANCE: LYON, FRANCE -- (Marketwired) -- 01/15/15 -- Flamel Technologies (NASDAQ: FLML) today announced that the Wholesale Acquisition Cost (WAC) for Bloxiverz has been increased to $98.75 per vial for both ...
VANCOUVER, BRITISH COLUMBIA: VANCOUVER, BRITISH COLUMBIA -- (Marketwired) -- 01/14/15 -- VANC Pharmaceuticals Inc. ("VANC" or the "Company") (TSX VENTURE: NPH)(OTCQB: NUVPF), a pharmaceutical company focused ...
TORONTO, ONTARIO: TORONTO, ONTARIO -- (Marketwired) -- 01/13/15 -- Canadian Cannabis Corp. ("CCAN" or the "Company") (OTCQB: CCAN) is pleased to announce the appointment of Mr. Richard Wachsberg t ...
